Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30990840 | 0.85 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL2198488 | 0.85 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL16153670 | 0.83 | CYP1A2 (0.50) | CYP1A2ALDH1A1MAPK1L3MBTL1HKDC1 | |
| SCHEMBL663504 | 0.80 | CYP1A2 (0.63) | CYP1A2ALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL30345509 | 0.80 | CYP1A2 (0.63) | CYP1A2ALDH1A1TSHRMAPK1HSD17B10 | |
| SCHEMBL20698361 | 0.80 | ALDH1A1 (0.49) | ALDH1A1TSHRMAPK1HSD17B10L3MBTL1 | |
| SCHEMBL12192934 | 0.80 | HSD17B1 (0.47) | CYP1A2ALDH1A1HSD17B10TP53HSD17B1 | |
| SCHEMBL24871313 | 0.79 | ESR1 (0.48) | CYP1A2ALDH1A1HSD17B10TP53HSD17B1 | |
| SCHEMBL2164353 | 0.79 | GSTP1 (0.52) | CYP1A2ALDH1A1HSD17B10TP53HSD17B1 | |
| SCHEMBL29541386 | 0.79 | GSTP1 (0.52) | CYP1A2ALDH1A1HSD17B10TP53HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9126887-B2 | Organic electroluminescent element material and organic electroluminescent element comprising same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-9126887-B2 | Organic electroluminescent element material and organic electroluminescent element comprising same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20110303907-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-15 | — | — | US | disclosed |
| US-20110303907-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110303907-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | L1CAM, EPCAM, LEF1 | CYP1A2 2927/4885ALDH1A1 1636/4885TSHR 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.